Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvio Matsas
Observed names:
S Matsas,
S. Matsas
Institution:
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Observed institution:
Faculdade de Ciências Médicas da Santa Casa de São Paulo
ORCID:
0000-0002-2674-6818
Observed ORCID:
0000-0002-2674-6818
OpenAlex ID:
A5014369271
Next-generation sequencing impact on cancer care: applications, challenges, and future directions
2024
·
Mariano Zalis
, Gilson Gabriel Viana Veloso
, et al.
·
Frontiers in Genetics
·
51
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis
2024
·
Silvio Matsas
, Pedro Nazareth Aguiar Jr
, et al.
·
Journal of Gastrointestinal Oncology
·
27
Evidence Strength of Pharmaceutical Industry-Funded Clinical Trials in Metastatic NSCLC: A Comparison With Other Sources of Funding
2020
·
Barbara de Souza Gutierres
, Pedro N. Aguiar
, et al.
·
Journal of Thoracic Oncology
·
11
PDF
Challenges and Opportunities in Building a Health Economic Framework for Personalized Medicine in Oncology
2023
·
Pedro Nazareth Aguiar
, Silvio Matsas
, et al.
·
Personalized Medicine
·
9
Prognostic role of platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in advanced gastric cancer treated with immunotherapy: A systematic review and meta-analysis.
2024
·
Silvio Matsas
, Pedro N. Aguiar Junior
, et al.
·
Journal of Clinical Oncology
·
8
Efficacy and safety of camrelizumab combined with chemotherapy in the first-line treatment of advanced gastric cancer: a single-arm, phase II study
2024
·
Wenlou Liu
, Hongmei Wang
, et al.
·
Journal of Gastrointestinal Oncology
·
5
CMTM4 inhibits gastric tumorigenesis and metastasis
2024
·
Xiurui Han
, Weiwei Fu
, et al.
·
Journal of Gastrointestinal Oncology
·
3
Inappropriate use of tumor markers for GI cancer screening in asymptomatic patients: A systematic review and proposed follow-up framework.
2026
·
Silvio Matsas
, Allan Roberto Bueso Pineda
, et al.
·
Journal of Clinical Oncology
·
2
Inappropriate Use of Tumor Markers in Asymptomatic Patients: A Systematic Review and Proposed Follow-Up Algorithm
2026
·
Silvio Matsas
, Allan Roberto Bueso Pineda
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
1
PDF
Prognostic role of miR-190, miR-221, and miR-381 in breast cancer: a systematic review and meta-analysis.
2025
·
S Matsas
, A Ruiz Simões
, et al.
·
PubMed
·
1
Low expression of PRTN3 regulates the progression of gastric cancer by inhibition of cell cycle and promotion of apoptosis
2025
·
Haoyu Zhu
, Fei Wang
, et al.
·
Translational Cancer Research
·
1
Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies
2026
·
Silvio Matsas
, Julita Zembala
, et al.
·
Asian Pacific Journal of Cancer Prevention
PDF
Efficacy of Phytotherapy for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2026
·
Silvio Matsas
, Ursula Medeiros Araujo de Matos
, et al.
·
Diseases
PDF
Prognostic utility of inflammatory indices and circulating nucleic acids for neoadjuvant chemotherapy outcomes in breast cancer: a systematic review
2025
·
Silvio Matsas
, Anderson Ruiz Simões
, et al.
·
Therapeutic Advances in Medical Oncology
P3.12C.07 Breaking New Ground: Selecting the Best Treatment for Non-Small Cell Lung Cancer According to Mutational Status
2024
·
J.H. Maselli Schoueri
, P. Nazareth Aguiar
, et al.
·
Journal of Thoracic Oncology
PDF
EP08.02-042 EGFR-TKI +/- Antiangiogenics for EGFR-mutated Advanced NSCLC
2022
·
L.L. da Silva
, S. Matsas
, et al.
·
Journal of Thoracic Oncology
P10.01 Bias Comparison in Studies Funded by Industry and by Other Sources: An Analysis of Prospective Studies of the Last Five Years
2021
·
S. Matsas
, A. Simões
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
17
Citation count:
119
H-index:
5
I10-index:
3
Year
Topic
Type